Clinical Trial Update: A Phase II Trial of Ifosfamide, Etoposide, Cytarabine, and Methotrexate (IVAM) Chemotherapy for Refractory or Relapsed Diffuse Large B Cell Lymphoma [Phase 2]

View source ↗

Summary

Phase II trial evaluating IVAM chemotherapy (Ifosfamide, Etoposide, Cytarabine, Methotrexate) for refractory or relapsed diffuse large B-cell lymphoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diffuse Large B-cell Lymphoma

Drugs mentioned

• IVAM chemotherapy

Snippet

Sponsor: Asan Medical Center | Conditions: Diffuse Large B Cell Lymphoma | Phase 2 | Status: UNKNOWN